Abstract:Objectives Early placement of transjugular intrahepatic portosystemic shunt (TIPS) has been shown to improve survival in high-risk patients (Child-Pugh B plus active bleeding at endoscopy or Child-Pugh C 10-13) with cirrhosis and acute variceal bleeding (AVB). However, early TIPS criteria may overestimate the mortality risk in a significant proportion of patients, and the survival benefit conferred by early TIPS in such patients has been questioned. Alternative criteria have been proposed to refine the criteria used to identify candidates for early TIPS. Nevertheless, the true survival benefit provided (or not) by early TIPS compared with standard treatment in the different risk categories has not been investigated in specifically designed comparative studies. Design We collected data on 1425 consecutive patients with cirrhosis and AVB who were admitted to 12 university hospitals in China between December 2010 and June 2016. Of these, 206 patients received early TIPS, and 1219 patients received standard treatment. The Fine and Gray competing risk regression model was used to compare the outcomes between the two groups that were stratified based on the currently available risk stratification systems after adjusting for liver disease severity and other potential confounders. Results Overall, early TIPS was associated with an 80% relative risk reduction (RRR) in mortality at 6 weeks (adjusted HR=0.20; 95% CI : 0.10 to 044; p<0.001) and 51% RRR at 1 year (adjusted HR=0.49, 95% CI : 0.32 to 0.73; p<0.001) compared with standard treatment. In stratification analyses, the RRRs in mortality did not significantly differ among the risk categories. However, the absolute risk reductions (ARRs) of mortality were more pronounced in high-risk patients. The ARRs at 6 weeks were -2.1%, -10.2% and -32.4% in Model for End-stage Liver Disease (MELD) <= 11, 12-18 and >= 19 patients and were -1.5%, -9.1% and -23.2% in Child-Pugh A, B and C patients, respectively (interaction tests, p<0.001 for both criteria). The ARRs for mortality at 1 year were -1.7%, -5.4% and -32.7% in MELD <= 11, 12-18 and >= 19 patients, respectively, and -3.6%, -5.2% and -20.3% in Child-Pugh A, B and C patients, respectively (interaction tests, p<0.001 for both criteria). After adjusting for liver disease severity and other potential confounders, a survival benefit was observed in MELD >= 19 or Child-Pugh C patients but not in MELD <= 11 or Child-Pugh A patients. In MELD 12-18 patients, a survival benefit was observed within 6 weeks but not at 1 year. In Child-Pugh B patients, a survival benefit was observed in those with active bleeding but not those without active bleeding. However, the evaluation of active bleeding was associated with a high interobserver variability. Furthermore, early TIPS was associated with a significantly reduced incidence of failure to control bleeding or rebleeding and new or worsening ascites, without increasing the risk of overt hepatic encephalopathy. Conclusions Early TIPS was associated with improved survival in patients with MELD >= 19 or Child-Pugh C cirrhosis but not in patients with MELD <= 11 or Child-Pugh A cirrhosis. For MELD 12-18 or ChildPugh B patients, future studies addressing optimal selection criteria for early TIPS remain highly warranted.

Prevalence, clinical characteristics, and outcomes of spontaneous portosystemic shunt in patients with hepatitis B-related cirrhosis: A multicenter study from China

Spontaneous portosystemic shunt as a potiential marker for severe liver damage and high risk of complications associated with portal hypertension in patients with hepatitis B-related cirrhosis: a multicenter study from China

Spontaneous portosystemic shunts outside the esophago-gastric region: Prevalence, clinical characteristics, and impact on mortality in cirrhotic patients: A systematic review and meta-analysis.

Relations between spontaneous portosystemic shunts and outcomes in hepatitis B virus-related cirrhotic patients with esophagogastric variceal bleeding after repeated endotherapy

Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis

Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis

Clinical Implications and Management of Spontaneous Portosystemic Shunts in Liver Cirrhosis

Portopulmonary hypertension in cirrhotic patients: Prevalence, clinical features and risk factors.

A Single Hospital Study on Portal Vein Thrombosis in Cirrhotic Patients - Clinical Characteristics & Risk Factors.

Comparison of Transjugular Intrahepatic Portosystemic Shunt for Treatment of Variceal Bleeding in Patients with Cirrhosis with or Without Spontaneous Portosystemic Shunt

Identifying Optimal Candidates for Early TIPS among Patients with Cirrhosis and Acute Variceal Bleeding: a Multicentre Observational Study

Prevention of variceal rebleeding in cirrhotic patients with spontaneous portosystemic shunts: transjugular intrahepatic portosystemic shunt versus endoscopic treatment

Prevalence and Clinical Significance of Portal Vein Thrombosis in Patients With Cirrhosis and Acute Decompensation

The Role of Spontaneous Portal-Systemic Shunts in Liver Transplantation: Case Report and Literature Review

Prevalence and Clinical Significance of Portal Vein Thrombosis in Cirrhotic Patients with Acute Decompensation

Clinical characteristics and natural history of porto‐sinusoidal vascular disease: A cohort study of 234 patients in China

Safety and efficacy of interventional embolization in cirrhotic patients with refractory hepatic encephalopathy associated with spontaneous portosystemic shunts

Su1505 Shear Wave Elastography for the Assessment of Portal Hypertension Before and After Transjugular Intrahepatic Portosystemic Shunt Implantation, a Pilot Study

Concurrent large spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: A randomized controlled trial

Comparison of Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Cirrhosis With or Without Portal Vein Thrombosis: A Retrospective Study

Interventional embolisation for patients with cirrhosis and recurrent or persistent hepatic encephalopathy related to spontaneous portosystemic shunts: protocol for a prospective, non-randomised controlled study